Ghent University Academic Bibliography

Your filters: cql: author="Beirnaert, E" or (type any "bookEditor issueEditor" and editor="Beirnaert, E")

Add to list
- Journal Article
- A1
Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis

Klaas Vandenbroucke, H de Haard, E Beirnaert, T Dreier, M Lauwereys, Lynn Huyck (UGent) , Jacques Van Huysse (UGent) , P Demetter, L Steidler, Erik Remaut (UGent) , et al.

(2010) MUCOSAL IMMUNOLOGY. 3(1). p.49-56
Add to list
- Journal Article
- A1
The intraspleen huPBL NOD/SCID model to study the human HIV-specific antibody response selected in the course of natural infection

Sophia Steyaert (UGent) , Lieven Verhoye (UGent) , E BEIRNAERT, H DONNERS, K FRANSEN, L HEYNDRICKX, G VANHAM, Geert Leroux-Roels (UGent) and Peter Vanlandschoot (UGent)

(2007) JOURNAL OF IMMUNOLOGICAL METHODS. 320(1-2). p.49-57
Add to list
- Journal Article
- A1
Potent broad cross-neutralizing sera inhibit attachment of primary HIV-1 isolates (groups M and O) to peripheral blood mononuclear cells.

E BEIRNAERT, S DE ZUTTER, W JANSSENS and G VAN DER GROEN

(2001) VIROLOGY. 281(2). p.305-314
Add to list
- Journal Article
- A1
Interpatient genetic variability of HIV-1 group O.

W JANSSENS, L HEYNDRICKX, G VAN DER AUWERA, J NKENGASONG, E BEIRNAERT, K VEREECKEN, S COPPENS, B WILLEMS, K FRANSEN, Marc Peeters (UGent) , et al.

(1999) AIDS. 13(1). p.41-48
Add to list
An antibody which binds to the membrane-proximal end of influenza virus haemagglutinin (H3 subtype) inhibits the low-pH-induced conformational change and cell-cell fusion but does not neutralize virus.

Peter Vanlandschoot, E BEIRNAERT, B BARRERE, L CALDER, B MILLAR, S WHARTON, Willy Min Jou (UGent) and Walter Fiers

(1998) JOURNAL OF GENERAL VIROLOGY.
Add to list
- Journal Article
- A1
Genetic variation of HIV type 1: Relevance of interclade variation to vaccine development.

G VAN DER GROEN, PN NYAMBI, E BEIRNAERT, D DAVIS, K FRANSEN, L HEYNDRICKX, P ONDOA, G VAN DER AUWERA and W JANSSENS

(1998) AIDS RESEARCH AND HUMAN RETROVIRUSES.

Academic Bibliography

Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis

The intraspleen huPBL NOD/SCID model to study the human HIV-specific antibody response selected in the course of natural infection

Potent broad cross-neutralizing sera inhibit attachment of primary HIV-1 isolates (groups M and O) to peripheral blood mononuclear cells.

Interpatient genetic variability of HIV-1 group O.

An antibody which binds to the membrane-proximal end of influenza virus haemagglutinin (H3 subtype) inhibits the low-pH-induced conformational change and cell-cell fusion but does not neutralize virus.

Genetic variation of HIV type 1: Relevance of interclade variation to vaccine development.

Contents

Support

Contact